Theratechnologies (THTX)
(Delayed Data from NSDQ)
$1.55 USD
-0.02 (-0.96%)
Updated Jul 23, 2024 03:59 PM ET
After-Market: $1.54 -0.01 (-0.32%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Cash flow Statements
Fiscal Year End for Theratechnologies Inc falls in the month of November.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -23.96 | -47.24 | -31.73 | -22.67 | -12.50 |
Depreciation/Amortization & Depletion | 3.32 | 12.47 | 8.75 | 8.52 | 7.50 |
Net Change from Assets/Liabilities | 8.13 | 13.46 | 0.24 | -6.27 | -3.66 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.83 | 6.61 | 8.26 | 6.87 | 5.27 |
Net Cash From Operating Activities | -5.68 | -14.69 | -14.48 | -13.55 | -3.39 |
Property & Equipment | -0.32 | -0.99 | -0.13 | -0.03 | -1.22 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 2.93 | 9.67 | -12.12 | 4.41 | 2.29 |
Other Investing Activities | -1.50 | 0.00 | -0.21 | 0.40 | -1.21 |
Net Cash from Investing Activities | 1.11 | 8.68 | -12.45 | 4.78 | -0.13 |
Uses of Funds
11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 25.16 | 2.98 | 47.34 | 0.15 | 0.11 |
Issuance (Repayment) of Debt | -7.45 | 11.25 | -5.00 | -3.50 | -3.50 |
Increase (Decrease) Short-Term Debt | -0.45 | -0.68 | -0.64 | -0.57 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.48 | -3.90 | -7.15 | -3.31 | -3.42 |
Net Cash from Financing Activities | 14.78 | 9.66 | 34.56 | -7.23 | -6.81 |
Effect of Exchange Rate Changes | 0.04 | -0.19 | 0.04 | 0.08 | -0.01 |
Net Change In Cash & Equivalents | 10.24 | 3.46 | 7.66 | -15.92 | -10.34 |
Cash at Beginning of Period | 23.86 | 20.40 | 12.74 | 28.66 | 39.00 |
Cash at End of Period | 34.10 | 23.86 | 20.40 | 12.74 | 28.66 |
Diluted Net EPS | -0.91 | -2.00 | -1.36 | -1.16 | -0.64 |
Fiscal Year End for Theratechnologies Inc falls in the month of November.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -3.49 | -4.48 | -23.96 | -21.20 | -20.46 |
Depreciation/Amortization & Depletion | 1.78 | 0.52 | 3.32 | 2.74 | 1.87 |
Net Change from Assets/Liabilities | -1.49 | 1.42 | 8.13 | 13.60 | 7.00 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.20 | 0.84 | 6.83 | 3.29 | 4.68 |
Net Cash From Operating Activities | -2.00 | -1.71 | -5.68 | -1.57 | -6.90 |
Property & Equipment | NA | 0.00 | -0.32 | -0.32 | -0.30 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 1.50 | 0.13 | 2.93 | 1.28 | 0.71 |
Other Investing Activities | -1.50 | 0.00 | -1.50 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.13 | 1.11 | 0.97 | 0.41 |
Uses of Funds
5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 25.16 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | -7.45 | -7.45 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.24 | -0.12 | -0.45 | -0.33 | -0.22 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.67 | -0.15 | -2.48 | -0.53 | -0.18 |
Net Cash from Financing Activities | -0.91 | -0.28 | 14.78 | -8.32 | -0.40 |
Effect of Exchange Rate Changes | -0.02 | -0.01 | 0.04 | 0.03 | 0.00 |
Net Change In Cash & Equivalents | -2.93 | -1.86 | 10.24 | -8.89 | -6.90 |
Cash at Beginning of Period | 34.10 | 34.10 | 23.86 | 23.86 | 23.86 |
Cash at End of Period | 31.17 | 32.24 | 34.10 | 14.97 | 16.96 |
Diluted Net EPS | 0.02 | -0.10 | -0.04 | -0.03 | -0.40 |